Table 2:
Characteristic | Overall n=41 | Believes COT keeps HIV-pts engaged n=22 | Does not believe COT keeps HIV-pts engaged n=19 | p-value |
---|---|---|---|---|
Conducts urine drug tests | 14 (34%) | 11 (50%) | 3 (16%) | 0.02 |
Uses treatment agreements | 11 (27%) | 8 (36%) | 3 (16%) | 0.14 |
Uses prescription monitoring programs | 7 (17%) | 5 (23%) | 2 (11%) | 0.16* |
Routine use of urine drug tests, treatment agreements, or PMP |
20 (49%) | 13 (59%) | 7 (37%) | 0.16 |
Screens for misuse using validated tool | 3 (7%) | 2 (9%) | 1 (5%) | 1.00* |
Uses scheduled pill counts | 0 (0%) | 0 (0%) | 0 (0%) | |
Refuses early opioid refills | 22 (54%) | 14 (64%) | 8 (42%) | 0.17 |
Discusses: | ||||
Drug-drug interactions | 25 (61%) | 11 (50%) | 14 (74%) | 0.12 |
Diversion | 8 (20%) | 5 (23%) | 3 (17%) | 0.71* |
Safe storage of medications | 8 (20%) | 7 (32%) | 1 (5%) | 0.05* |
Alcohol use | 24 (59%) | 8 (36%) | 16 (84%) | <0.01 |
Illicit drug use | 33 (81%) | 16 (73%) | 17 (90%) | 0.25* |
Marijuana use | 13 (32%) | 6 (27%) | 7 (37%) | 0.51 |
Over-sedation | 23 (56%) | 12 (55%) | 11 (58%) | 0.83 |
Overdose | 17 (42%) | 8 (36%) | 9 (47%) | 0.48 |
Fisher’s exact test. All others reported are chi-square tests.